Cargando…
Preclinical to clinical translation of anti-PD-1 blockade
Autores principales: | Hirsch, Heather, Pinheiro, Elaine, Ayers, Mark, Lunceford, Jared, Nebozhyn, Michael, Murphy, Erin, Cai, Mingmei, Ma, Yanhong, Sathe, Manjiri, McClanahan, Terri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645290/ http://dx.doi.org/10.1186/2051-1426-3-S2-P92 |
Ejemplares similares
-
Relationship between immune gene signatures and clinical response to PD-1 blockade with pembrolizumab (MK-3475) in patients with advanced solid tumors
por: Ayers, Mark, et al.
Publicado: (2015) -
Reverse Translating Molecular Determinants of Anti–Programmed Death 1 Immunotherapy Response in Mouse Syngeneic Tumor Models
por: Georgiev, Peter, et al.
Publicado: (2022) -
In vivo identification of novel STAT5 target genes
por: Basham, Beth, et al.
Publicado: (2008) -
Transcriptomic Determinants of Response to Pembrolizumab Monotherapy across Solid Tumor Types
por: Cristescu, Razvan, et al.
Publicado: (2022) -
Tuberculosis from a Dental Standpoint
por: McClanahan, A. A.
Publicado: (1912)